Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 8/2003

01.08.2003 | Original Article

Rapid normalization of osseous FDG uptake following traumatic or surgical fractures

verfasst von: Hongming Zhuang, Joseph W. Sam, Thomas K. Chacko, Paulo S. Duarte, Marc Hickeson, Qi Feng, Kozaim Z. Nakhoda, Liang Guan, Phillip Reich, Shirley M. Altimari, Abass Alavi

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 8/2003

Einloggen, um Zugang zu erhalten

Abstract

It is known that following a traumatic fracture or surgical intervention, bone scintigraphy reveals positive results for an extended period of time, posing a challenge when evaluating patients for possible malignancy or superimposed osteomyelitis. Previous reports indicate that acute fractures can also result in increased fluorine-18 fluorodeoxyglucose (FDG) accumulation and therefore cause difficulties when patients are evaluated for other indications by FDG-PET. The purpose of this study was to assess the pattern and time course of abnormal FDG uptake following traumatic or surgical fracture. A total of 1,517 consecutive patients who underwent whole-body FDG-PET imaging were retrospectively studied. A history of fractures or orthopedic intervention was obtained from an interview prior to scanning. The FDG-PET results were compared with the results of other imaging studies, including bone scans, radiographs, CT, and MRI, as well as surgical pathology reports. Thirty-seven patients with a known date of traumatic or surgical fracture were identified. Among these, 14 had fractures or surgery within 3 months prior to FDG-PET, while 23 had fractures or surgical intervention greater than 3 months prior to FDG-PET. FDG-PET showed no abnormally increased uptake at the known fracture or surgical sites in 30 of these patients. Notably, in the 23 patients with fractures more than 3 months old, all but one showed no abnormally increased uptake. Furthermore, the positive FDG uptake in this exception was a result of complicating osteomyelitis. In the 14 patients with a history of fracture less than 3 months old, only six had abnormally increased FDG uptake. Following traumatic or surgical fractures, FDG uptake is expected to be normal within 3 months unless the process is complicated by infection or malignancy.
Literatur
1.
Zurück zum Zitat Matin P. Appearance of bone scans following fractures, including immediate and long-term studies. J Nucl Med 1979; 20:1227–1231. Matin P. Appearance of bone scans following fractures, including immediate and long-term studies. J Nucl Med 1979; 20:1227–1231.
2.
Zurück zum Zitat Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000; 41:1695–1701.PubMed Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000; 41:1695–1701.PubMed
3.
Zurück zum Zitat Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219:774–777.PubMed Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219:774–777.PubMed
4.
Zurück zum Zitat Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998; 91:3340–3346.PubMed Carr R, Barrington SF, Madan B, et al. Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 1998; 91:3340–3346.PubMed
5.
Zurück zum Zitat Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998; 39:2145–2152.PubMed Guhlmann A, Brecht-Krauss D, Suger G, et al. Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998; 39:2145–2152.PubMed
6.
Zurück zum Zitat Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25:281–284.PubMed Zhuang H, Duarte PS, Pourdehand M, Shnier D, Alavi A. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin Nucl Med 2000; 25:281–284.PubMed
7.
Zurück zum Zitat Schmitz A, Risse HJ, Kalicke T, Grunwald F, Schmitt O. FDG-PET for diagnosis and follow-up of inflammatory processes: first results from an orthopedic view. Z Orthop Grenzg 2000; 138:407–412.CrossRef Schmitz A, Risse HJ, Kalicke T, Grunwald F, Schmitt O. FDG-PET for diagnosis and follow-up of inflammatory processes: first results from an orthopedic view. Z Orthop Grenzg 2000; 138:407–412.CrossRef
8.
Zurück zum Zitat Zhuang H, Duarte PS, Pourdehnad M, et al. The promising role of F-18-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 2001; 42:44–48.PubMed Zhuang H, Duarte PS, Pourdehnad M, et al. The promising role of F-18-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 2001; 42:44–48.PubMed
9.
Zurück zum Zitat Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H and Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000; 27:1305–1311.PubMed Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H and Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000; 27:1305–1311.PubMed
10.
Zurück zum Zitat Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 1999; 40:1407.PubMed Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 1999; 40:1407.PubMed
11.
Zurück zum Zitat Meyer M, Gast T, Raja S, Hubner K. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med 1994; 19:13–14.PubMed Meyer M, Gast T, Raja S, Hubner K. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med 1994; 19:13–14.PubMed
12.
Zurück zum Zitat Karp JS, Muehllehner G, Qu H, Yan XH. Singles transmission in volume-imaging PET with a137Cs source. Phys Med Biol 1995; 40:929–944.PubMed Karp JS, Muehllehner G, Qu H, Yan XH. Singles transmission in volume-imaging PET with a137Cs source. Phys Med Biol 1995; 40:929–944.PubMed
13.
Zurück zum Zitat Bedigian MP, Benard F, Smith RJ, Karp JS, Alavi A. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets expectation maximization (OS-EM) reconstruction. Eur J Nucl Med 1998; 25:659–661.PubMed Bedigian MP, Benard F, Smith RJ, Karp JS, Alavi A. Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets expectation maximization (OS-EM) reconstruction. Eur J Nucl Med 1998; 25:659–661.PubMed
14.
Zurück zum Zitat Ma LD, Frassica FJ, Bluemke DA, Fishman EK. CT and MRI evaluation of musculoskeletal infection. Crit Rev Diagn Imaging 1997; 38:535–568.PubMed Ma LD, Frassica FJ, Bluemke DA, Fishman EK. CT and MRI evaluation of musculoskeletal infection. Crit Rev Diagn Imaging 1997; 38:535–568.PubMed
15.
Zurück zum Zitat Seabold JE, Nepola JV. Imaging techniques for evaluation of postoperative orthopedic infections. Q J Nucl Med 1999; 43:21–28.PubMed Seabold JE, Nepola JV. Imaging techniques for evaluation of postoperative orthopedic infections. Q J Nucl Med 1999; 43:21–28.PubMed
16.
Zurück zum Zitat Kalicke T, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000; 27:524–528.PubMed Kalicke T, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000; 27:524–528.PubMed
17.
Zurück zum Zitat Paul R, Ahonen A, Virtama P, Aho A, Ekfors T. F-18 fluorodeoxyglucose—its potential in differentiating between stress-fracture and neoplasia. Clin Nucl Med 1989; 14:906–908.PubMed Paul R, Ahonen A, Virtama P, Aho A, Ekfors T. F-18 fluorodeoxyglucose—its potential in differentiating between stress-fracture and neoplasia. Clin Nucl Med 1989; 14:906–908.PubMed
18.
Zurück zum Zitat Schmitz A, Risse JH, Textor J, Zander D, Biersack HJ, Palmedo H. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporosis Int 2002; 13:755–761.CrossRef Schmitz A, Risse JH, Textor J, Zander D, Biersack HJ, Palmedo H. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporosis Int 2002; 13:755–761.CrossRef
19.
Zurück zum Zitat De Winter F, Van de Wiele C, Vogelaers D, De Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001; 83:651–660. De Winter F, Van de Wiele C, Vogelaers D, De Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001; 83:651–660.
20.
Zurück zum Zitat Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 25:1244–1247.CrossRefPubMed Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 25:1244–1247.CrossRefPubMed
21.
Zurück zum Zitat Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP. Comparing whole body18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 2002; 49:267–271.PubMed Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP. Comparing whole body18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma 2002; 49:267–271.PubMed
22.
Zurück zum Zitat Wu HC, Yen RF, Shen YY, Kao CH, Lin CC and Lee CC. Comparing whole body18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients wih renal cell carcinomas—a preliminary report. J Cancer Res Clin Oncol 2002; 128:503–506.CrossRefPubMed Wu HC, Yen RF, Shen YY, Kao CH, Lin CC and Lee CC. Comparing whole body18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients wih renal cell carcinomas—a preliminary report. J Cancer Res Clin Oncol 2002; 128:503–506.CrossRefPubMed
23.
Zurück zum Zitat Charkes ND. Skeletal blood flow—Implications for bone scan interpretation. J Nucl Med 1980; 21:91–98.PubMed Charkes ND. Skeletal blood flow—Implications for bone scan interpretation. J Nucl Med 1980; 21:91–98.PubMed
Metadaten
Titel
Rapid normalization of osseous FDG uptake following traumatic or surgical fractures
verfasst von
Hongming Zhuang
Joseph W. Sam
Thomas K. Chacko
Paulo S. Duarte
Marc Hickeson
Qi Feng
Kozaim Z. Nakhoda
Liang Guan
Phillip Reich
Shirley M. Altimari
Abass Alavi
Publikationsdatum
01.08.2003
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 8/2003
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-003-1198-x

Weitere Artikel der Ausgabe 8/2003

European Journal of Nuclear Medicine and Molecular Imaging 8/2003 Zur Ausgabe